NCT01681576 - Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Salt-sensitive Hypertension

Interventions

DRUG

Valsartan

Valsartan 320mg tablet once daily

DRUG

LCZ696

LCZ696 400mg tablet once daily

Trial Locations (15)

112

Novartis Investigative Site, Taipei

114

Novartis Investigative Site, Taipei

10002

Novartis Investigative Site, Taipei

40447

Novartis Investigative Site, Taichung

90630

Novartis Investigative Site, Cypress

91206

Novartis Investigative Site, Glendale

92801

Novartis Investigative Site, Anaheim

119228

Novartis Investigative Site, Singapore

169609

Novartis Investigative Site, Singapore

Unknown

Novartis Investigative Site, Hong Kong

424-717

Novartis Investigative Site, Bucheon-si

410-773

Novartis Investigative Site, Koyang-si

110 744

Novartis Investigative Site, Seoul

120-752

Novartis Investigative Site, Seoul

152-703

Novartis Investigative Site, Seoul